Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$29.5 - $39.5 $8,850 - $11,850
-300 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$29.86 - $39.47 $564,354 - $745,983
-18,900 Reduced 98.44%
300 $0
Q2 2021

Jul 19, 2021

BUY
$17.99 - $40.02 $302,232 - $672,336
16,800 Added 700.0%
19,200 $152,000
Q1 2021

Apr 26, 2021

BUY
$16.0 - $24.46 $12,800 - $19,568
800 Added 50.0%
2,400 $6,000
Q4 2020

Jan 21, 2021

BUY
$15.89 - $40.87 $25,424 - $65,391
1,600 New
1,600 $6,000

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $33.8M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.